Fungal pathogens susceptible to cladodionen secondary metabolite

Fungal pathogens susceptible to cladodionen secondary metabolite refers to a group of phytopathogenic fungi that exhibit growth inhibition when exposed to the bioactive compound cladodionen. Cladodionen is a secondary metabolite, specifically a chromone derivative, isolated from fungi such as Cladosporium cladosporioides (Li et al., 2014). It demonstrates significant antifungal activity against economically important pathogens, including Colletotrichum gloeosporioides and Magnaporthe oryzae, which are responsible for substantial agricultural crop losses (PubChem). The compound effectively suppresses the germination of fungal spores and the development of mycelia, making it a candidate for the development of natural fungicides. Despite its potent biological effects, a specific molecular target, such as a single enzyme or receptor protein, has not been definitively identified in standard pharmacological databases like UniProt. Research suggests that its action may involve broad disruption of fungal metabolic pathways or cellular integrity. In addition to its antifungal properties, cladodionen has shown cytotoxic effects against various human cancer cell lines in vitro, indicating a potential for broader biological applications (Li et al., 2014). This target designation highlights the spectrum of organisms affected by the metabolite rather than a specific biochemical interaction site.

Other names

Cladodionen-sensitive fungiPhytopathogenic fungiCladodionene-susceptible fungiCladosporium-derived metabolite targets

Inhibition of fungal spore germination and mycelial growth through potentially non-specific disruption of cellular metabolism or membrane integrity (Li et al., 2014).